Bean Gum and Mouth Cancer Prevention
A research team from the University of Pennsylvania School of Dental Medicine has successfully developed an innovative therapeutic chewing gum capable of targeting three types of microbes associated with oral cancer, particularly the human papillomavirus (HPV), which is the most prevalent through sexual contact. The gum demonstrated a high ability to reduce the presence of the virus in saliva by up to 93%. The mechanism relies on a protein called FRIL, extracted from the scarlet kidney bean plant, which binds to viruses and prevents them from penetrating cells, thereby helping to reduce the transmission of infection. It is anticipated that clinical trials will be completed and necessary approvals obtained before this product can be used as an adjunct treatment alongside traditional methods for oral cancer. Additionally, the production costs are expected to be low, making it potentially accessible to the public in the future without the need for a prescription.
Notice: This Is an AI-Generated Summary
Comments (0)